An Liu Selected Research

Lymphatic Irradiation

1/2022	Total Marrow and Lymphoid Irradiation with Post-Transplantation Cyclophosphamide for Patients with AML in Remission.
1/2021	The safety and efficacy of a novel hypo-fractionated total marrow and lymphoid irradiation before allogeneic stem cell transplantation for lymphoma and acute leukemia.
12/2018	Feasibility of a novel dose fractionation strategy in TMI/TMLI.
4/2017	Phase I Trial of Total Marrow and Lymphoid Irradiation Transplantation Conditioning in Patients with Relapsed/Refractory Acute Leukemia.
1/2009	Image-guided total-marrow irradiation using helical tomotherapy in patients with multiple myeloma and acute leukemia undergoing hematopoietic cell transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

An Liu Research Topics

Disease

43	Neoplasms (Cancer) 07/2022 - 12/2003
13	Inflammation (Inflammations) 01/2022 - 04/2015
10	Infections 07/2021 - 09/2002
9	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 02/2011
7	Lung Neoplasms (Lung Cancer) 03/2022 - 06/2010
6	Pain (Aches) 01/2022 - 01/2015
6	Neoplasm Metastasis (Metastasis) 09/2017 - 02/2009
5	Leukemia 01/2021 - 01/2009
5	Wounds and Injuries (Trauma) 01/2018 - 03/2007
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 01/2009
4	Multiple Myeloma 01/2022 - 01/2009
4	Neuroinflammatory Diseases 02/2021 - 01/2020
4	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 01/2016
4	Esophageal Neoplasms (Esophageal Cancer) 02/2012 - 01/2007
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2022 - 02/2016
3	Hypoxia (Hypoxemia) 01/2022 - 01/2016
3	AIDS-Related Complex (ARC) 08/2021 - 01/2015
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 01/2009
3	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 03/2019
3	Non-alcoholic Fatty Liver Disease 09/2020 - 11/2018
3	Aneuploidy (Aneuploid) 01/2020 - 02/2014
3	Colorectal Neoplasms (Colorectal Cancer) 01/2016 - 12/2003
3	Glioma (Gliomas) 05/2013 - 04/2005
3	Anus Neoplasms (Anal Cancer) 09/2012 - 09/2005
3	Brain Neoplasms (Brain Tumor) 11/2009 - 08/2006
2	Ischemia 01/2022 - 01/2021
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 06/2021
2	Nasopharyngeal Carcinoma 08/2021 - 10/2020
2	Hyperthermia 01/2021 - 05/2015
2	Enteritis 01/2021 - 01/2011
2	Intellectual Disability (Idiocy) 01/2021 - 01/2017
2	Cognitive Dysfunction 01/2021 - 01/2021
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2021 - 01/2009
2	Adenocarcinoma 01/2021 - 01/2007
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2019
2	Brain Edema (Cerebral Edema) 12/2020 - 07/2016
2	Ganglion Cysts (Ganglion) 10/2020 - 01/2018
2	Trisomy (Trisomies) 01/2020 - 01/2018
2	Obesity 01/2019 - 01/2016
2	Hepatitis B 01/2019 - 11/2018
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2019 - 09/2002
2	Hematologic Neoplasms (Hematological Malignancy) 12/2018 - 12/2003
2	Osteoporosis 10/2018 - 01/2017
2	Breast Neoplasms (Breast Cancer) 03/2016 - 04/2011

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 10/2022 - 06/2010
8	Emodin (Archin)IBA 05/2012 - 02/2011
7	Gemcitabine FDA Link 01/2021 - 02/2011
5	Pharmaceutical PreparationsIBA 01/2021 - 01/2005
5	MicroRNAs (MicroRNA)IBA 01/2021 - 02/2016
5	Small Interfering RNA (siRNA)IBA 11/2019 - 01/2016
4	Freund's AdjuvantIBA 01/2022 - 01/2019
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2020
4	MatrinesIBA 04/2021 - 11/2018
4	EnzymesIBA 01/2021 - 01/2017
4	AntibodiesIBA 01/2021 - 12/2003
4	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 03/2007
4	Messenger RNA (mRNA)IBA 01/2018 - 08/2010
3	Biological ProductsIBA 10/2022 - 06/2010
3	Anti-Anxiety Agents (Anxiolytics)IBA 07/2021 - 01/2019
3	Antidepressive Agents (Antidepressants)IBA 02/2021 - 01/2018
3	LipopolysaccharidesIBA 01/2021 - 01/2016
3	oxidized low density lipoproteinIBA 01/2019 - 01/2017
3	Caspase 3 (Caspase-3)IBA 07/2016 - 12/2005
2	tanshinoneIBA 10/2022 - 03/2014
2	AntioxidantsIBA 07/2022 - 01/2016
2	nuciferineIBA 04/2022 - 12/2020
2	Therapeutic UsesIBA 01/2022 - 01/2016
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 04/2017
2	Melphalan (Alkeran)FDA LinkGeneric 01/2022 - 01/2009
2	MineralsIBA 12/2021 - 01/2015
2	Phosphates (Orthophosphate)IBA 12/2021 - 01/2015
2	Antineoplastic Agents (Antineoplastics)IBA 02/2021 - 02/2011
2	NLR ProteinsIBA 02/2021 - 11/2020
2	TitaniumIBA 01/2021 - 01/2015
2	Monoclonal AntibodiesIBA 01/2021 - 06/2016
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 04/2011
2	Amyloid (Amyloid Fibrils)IBA 01/2021 - 03/2019
2	CollagenIBA 11/2019 - 12/2008
2	Peptides (Polypeptides)IBA 03/2019 - 04/2005
2	Ritonavir (Norvir)FDA Link 01/2019 - 01/2019
2	Lopinavir FDA Link 01/2019 - 01/2019
2	LipidsIBA 01/2019 - 01/2019
2	CytokinesIBA 01/2018 - 01/2015
2	LigandsIBA 01/2018 - 06/2016
2	SaponinsIBA 07/2016 - 03/2015

Therapy/Procedure

22	Therapeutics 10/2021 - 12/2003
17	Radiotherapy 03/2022 - 12/2003
13	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 08/2021 - 10/2006
6	Drug Therapy (Chemotherapy) 01/2021 - 12/2003
5	Lymphatic Irradiation 01/2022 - 01/2009
4	Cell Transplantation 01/2022 - 01/2009
3	Transplantation 01/2022 - 01/2009
3	Arthroplasty 07/2021 - 01/2015
3	Radioimmunotherapy 01/2021 - 12/2003
3	Conformal Radiotherapy 01/2014 - 01/2007
3	Neoadjuvant Therapy 01/2014 - 08/2004
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 07/2022 - 01/2019
2	Art Therapy 01/2022 - 01/2019
2	Stem Cell Transplantation 01/2021 - 01/2011
2	Injections 12/2020 - 08/2015